However, showing some biomarker potential in selected patients, inflammatory bowel disease characterized by high fecal calprotectin levels (>500 μg/g) also showed elevated urinary chemerin concentrations in comparison to patients with calprotectin levels below this threshold or healthy controls [196]. Here, RARRES2 is linked to inflammatory bowel disease.